Epoetin beta in the treatment of anemia in patients with advanced gastrointestinal cancer. Patients (n = 236) with progressive, measurable disease were randomized to three groups and received FU 2,600 ...
Phase I study of the novel anticancer drug PM00104 as a 24-hour IV infusion every 3 weeks (q3w) in patients (pts) with advanced solid tumors or lymphoma This is an ASCO Meeting Abstract from the 2009 ...
The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results